We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's Why You Should Buy Boise Cascade (BCC) Stock Now
Read MoreHide Full Article
Boise Cascade Company’s (BCC - Free Report) shares have gained more than 37% in the past year, outperforming the 13.3% growth of its industry. After all, overall outlook for the construction sector remains positive, with a healthy economy and strong job market continuing to drive stocks higher.
Moreover, the Zacks Consensus Estimate for earnings for both the first quarter and the current year has increased 50% and 20.3%, respectively, in the last 60 days, thus reflecting optimism in the stock’s earnings prospects (and share price), and substantiating its Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
What Makes Boise Cascade a Solid Pick?
Unique Business Model and Steller Performance: Boise Cascade is a wood products manufacturer and building materials distributor. The company’s distribution footmark in the country and vertical integration (internal manufacturing) uniquely position Boise Cascade to take advantage of a positive housing scenario. The company has 32 distribution locations spread across the United States. This helps Boise Cascade to serve a major metropolitan market. Again, by manufacturing some of the products it distributes, the company’s manufacturing business has greater access to the market.
Boise Cascade ended 2017 on an impressive note owing to robust quarterly results. Adjusted fourth-quarter earnings increased significantly to 28 cents per share from 3 cents a year ago. Revenues also grew 13% year over year on higher sales across the board.
Importantly, Building Materials Distribution segment’s (accounting for 73% of revenues and 55% EBITDA) sales increased 17% in 2017 driven by 9% higher price and 8% volume increase.
Solid Industry Fundamentals: The company’s business is exposed to new single-family housing construction market, and repair and remodel. The housing/homebuilding industry has been riding high on steady job and wage growth, and rapidly increasing household formation. There’s no denying that growing labor shortage and limited land availability are causes of concern. That said, the overall outlook for the residential construction industry remains positive with a healthy economy and strong job market that will continue to drive stocks higher. Boise Cascade also remains positive about the overall housing market, and expects to continue experiencing modest demand growth for the products it manufactures and distributes in 2018.
Solid Estimated EPS Growth: The company’s first-quarter earnings are expected to increase 73.1% year over year. The company’s EPS is expected to grow 39.8% for the current year, higher than the industry’s average projected growth of 27.7%.
Meanwhile, the company’s sales are expected to increase 11.1% in the current quarter and 7.7% for the current year.
The above mentioned tailwinds have made it a great pick in terms of Growth investment. The stock has a Growth Score of A.
Other Stocks to Consider
Other top-ranked stocks worth considering in the same space are Louisiana-Pacific Corporation (LPX - Free Report) , PotlatchDeltic Corporation (PCH - Free Report) and Trex Company, Inc. (TREX - Free Report) .
Louisiana-Pacific sports a Zacks Rank #1 and is likely to witness a rise of 16.3% in earnings for the current year.
PotlatchDeltic, a Zacks Rank #2 (Buy) stock, is expected to witness 26.3% growth in earnings this year.
Trex, also a Zacks Rank #2 stock, is expected to witness 32.9% growth in 2018 earnings.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
Here's Why You Should Buy Boise Cascade (BCC) Stock Now
Boise Cascade Company’s (BCC - Free Report) shares have gained more than 37% in the past year, outperforming the 13.3% growth of its industry. After all, overall outlook for the construction sector remains positive, with a healthy economy and strong job market continuing to drive stocks higher.
Moreover, the Zacks Consensus Estimate for earnings for both the first quarter and the current year has increased 50% and 20.3%, respectively, in the last 60 days, thus reflecting optimism in the stock’s earnings prospects (and share price), and substantiating its Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
What Makes Boise Cascade a Solid Pick?
Unique Business Model and Steller Performance: Boise Cascade is a wood products manufacturer and building materials distributor. The company’s distribution footmark in the country and vertical integration (internal manufacturing) uniquely position Boise Cascade to take advantage of a positive housing scenario. The company has 32 distribution locations spread across the United States. This helps Boise Cascade to serve a major metropolitan market. Again, by manufacturing some of the products it distributes, the company’s manufacturing business has greater access to the market.
Boise Cascade ended 2017 on an impressive note owing to robust quarterly results. Adjusted fourth-quarter earnings increased significantly to 28 cents per share from 3 cents a year ago. Revenues also grew 13% year over year on higher sales across the board.
Importantly, Building Materials Distribution segment’s (accounting for 73% of revenues and 55% EBITDA) sales increased 17% in 2017 driven by 9% higher price and 8% volume increase.
Solid Industry Fundamentals: The company’s business is exposed to new single-family housing construction market, and repair and remodel. The housing/homebuilding industry has been riding high on steady job and wage growth, and rapidly increasing household formation. There’s no denying that growing labor shortage and limited land availability are causes of concern. That said, the overall outlook for the residential construction industry remains positive with a healthy economy and strong job market that will continue to drive stocks higher. Boise Cascade also remains positive about the overall housing market, and expects to continue experiencing modest demand growth for the products it manufactures and distributes in 2018.
Solid Estimated EPS Growth: The company’s first-quarter earnings are expected to increase 73.1% year over year. The company’s EPS is expected to grow 39.8% for the current year, higher than the industry’s average projected growth of 27.7%.
Meanwhile, the company’s sales are expected to increase 11.1% in the current quarter and 7.7% for the current year.
The above mentioned tailwinds have made it a great pick in terms of Growth investment. The stock has a Growth Score of A.
Other Stocks to Consider
Other top-ranked stocks worth considering in the same space are Louisiana-Pacific Corporation (LPX - Free Report) , PotlatchDeltic Corporation (PCH - Free Report) and Trex Company, Inc. (TREX - Free Report) .
Louisiana-Pacific sports a Zacks Rank #1 and is likely to witness a rise of 16.3% in earnings for the current year.
PotlatchDeltic, a Zacks Rank #2 (Buy) stock, is expected to witness 26.3% growth in earnings this year.
Trex, also a Zacks Rank #2 stock, is expected to witness 32.9% growth in 2018 earnings.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>